Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Emili Díaz(Universitat Autònoma de Barcelona), Rafael Máñez(Universitat Autònoma de Barcelona), Thiago Lisboa(Hospital de Clínicas de Porto Alegre), Ignacio Martín‐Loeches(St. James's Hospital), Jan J. De Waele(Ghent University Hospital), Marta Ulldemolins(Bellvitge University Hospital), Muhammet Güven(Universitat Autònoma de Barcelona), Maria Deja(Humboldt-Universität zu Berlin), Christian Putensen(University Hospital Bonn), Despoina Koulenti(University of Thessaly)
Cited by 85
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k